Article
Ellex Medical Pty. Ltd. introduces the Laserex Solo laser for the treatmentof open-angle glaucoma.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Lupin receives FDA approval for Loteprednol Etabonate Ophthalmic Gel, 0.38%
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
ForSight Robotics completes $125M Series B funding to address global surgeon shortage
(EyePod) From idea to impact: Navigating ophthalmic innovation
Mount Sinai’s NYEE unveils Center for Refractive Solutions
Formosa Pharmaceuticals grants Harrow commercial rights in US to clobetasol propionate ophthalmic suspension 0.05% (BYQLOVI), terminates deal with Eyenovia